. A Model for Receptor-Mediated Response As expressed at the turn of the century by Ehrlich, cor-(A) The simplest two-state system can be described as a receptor pora non agunt nisi fixata, agents cannot act unless they interconverting between two states, Ra (active) and Ri (inactive), that bind. The cellular binding entity has been termed the are in equilibrium Ra → ← R i. KDi and KDa are the equilibrium dissociation receptor, a molecule that has the bifunctional properties constants for the inactive and active states, respectively. M is an of both recognition and signal activation. Receptors act isomerization constant ϭ Ra/Ri. More complex models exist but may surpass the extant data relevant to risk assessment of environmental via diverse mechanisms, however, and a plethora of toxins. signaling pathways orchestrate cellular regulation in re-(B) Effects of drugs on the relative concentration of two hypothetical sponse to extracellular cues, including agents endogeforms of a receptor, R a (active) and R i (inactive) , that are in equilibrium nous to organisms as well as those introduced from the Ra → ← R i. The relative distribution of the receptor between these environment. Despite the diversity and complexity of forms is differentially influenced by agonists (A), partial agonists molecular mechanisms that translate receptor occu-(P), competitive antagonists (C), and negative antagonists (N), also known as inverse agonists.
pancy to response, receptor theory provides a means Ross, 1996.) M, which describes the ratio of the receptors, R i /R a , that 1B). In theory, endocrine disruptors or other toxicological agents could interact with receptors as agonists, are in the inactive versus active states.
partial agonists, antagonists, or negative antagonists. Agents that preferentially interact with the R a state, At the Receptor Roundtable, extant understandings or elicit conformational changes converting the Ri to an of how diverse cellular receptors elicit physiological reRa state, are referred to as agonists. Agonists vary in sponses were reviewed, and are summarized below. their relative affinity for the Ra and Ri conformations, Since risk assessment typically involves extrapolations or states. A full agonist, like most endogenous agents, to concentrations of environmentally available agents preferentially interacts with R a such that, at a saturating (e.g., in ppm) that are unattainable experimentally, idenconcentrations, it drives the receptor population comtifying the interaction of an endocrine disruptor or xenopletely to the active state (cf. agent A in Figure 1B) .
biotic mechanistically provides the opportunity to make Some agonists have only a slightly greater affinity for those extrapolations based on a quantitative framework. R a than Ri and may elicit a diminished response even at Consequently, the state of the art overview of receptor saturating occupancy; these agents are referred to as mechanisms and signal transduction pathways explored partial agonists (shown as P in Figure 1B) . Agents that at the Receptor Roundtable served as a prelude to disbind with equal affinity to the R i and Ra states but whose cussions of how these molecular details, considered in occupancy of the receptor blocks agonist occupancy the context of receptor theory, might inform public polare called antagonists; such agents have no intrinsic icy for risk assessment. ability to modify cellular functions, but effectively block, Signal Transduction or competitively antagonize, agonist-elicited responses Figure 2 provides a schematic diagram of the diversity (shown as C in Figure 1B ). In contrast, agents exist (and by which extracellular cues regulate diverse cellular often have profound therapeutic value) that preferenfunctions, the overall process of which is referred to as tially interact with the R i state of the receptor; these signal transduction. Many neurotransmitters, for examnegative antagonists (or inverse agonists) as they are ple, interact with receptors that are themselves ion called, suppress any "basal," or agonist-independent, channels, as reviewed by Palmer Taylor (University of effects of the receptor as well as block agonist occuCalifornia, San Diego). Similarly, growth or differentiation factors as well as cytokines interact with cell surface pancy when agonists are present (shown as N in Figure receptors that are also the effector molecules, such as that exploit these tyrosine kinase cascades regulate protyrosine or serine/threonine kinases, reviewed by Roger cesses as diverse as growth, differentiation and apoptoDavis (University of Massachusetts, Worcester) and sis. This functional diversity arises from the existence Joan Massagué (Memorial Sloan Kettering Institute), reof three known MAP kinase pathways, dubbed erk, p38, spectively. In many cases, however, the receptor moleand JNK (JUN kinase), the latter two typically nonovercule is not also the effector. For the family of serpentine lapping pathways being preferentially activated by cellureceptors, agonist-activated receptors mediate these lar stressors, such as starvation, UV radiation, changes effects by first coupling to GTP-binding proteins (G proin Receptor Serine/Threonine Kinases ion channels. In this setting, both ligand recognition and
The transforming growth factor ␤ (TGF␤)-signaling pathreceptor activation are intrinsic to a single molecule, and way, reviewed by Joan Massagué , shows many paraone conformational change mediates the translocation digmatic similarities to signaling through receptor tyroof ‫5ف‬ ϫ 10 4 ions, providing an immediate amplification sine kinases, except that the catalytic activity inherent in of signal propagation either through ion translocation or TGF␤ receptor heterodimers is a Ser/Thr kinase whose the resulting membrane depolarization. For the nicotinic substrates include the recently discovered family of receptor, two binding sites for acetylcholine, the native SMAD proteins (reviewed in Massagué , 1996) . Three agonist, exist on this pentameric molecule, and the resubunits exist for the TGF␤ receptor, designated as the sponse is positively cooperative. This cooperativity pertype I, II, or III receptor subunits. Heterodimerization of mits dramatic responses to small changes in agonists.
the type I with the type II receptor subunit constitutes However, if toxic agents or environmental pollutants an active receptor. The role of the type III receptor, were to interact with ligand-gated ion channels in a and its contribution to signaling, if it occurs, has not similar fashion, the cooperativity in ligand activation been definitively established. TGF␤, or activin, receptorwould approach a threshold phenomenon, thus precludmediated phosphorylation of homodimeric forms of the ing linear or direct extrapolation to concentrations suffi-SMAD2 or -3 isoforms (or SMAD1, -5, or -9 isoforms by ciently low to prevent a response.
the functionally homologous bone morphogenic peptide Receptor Tyrosine Kinases receptor) results in a phosphorylation-dependent dissoRoger Davis reviewed the plethora of signaling casciation of the homodimeric complex and association cades activated by the receptor tyrosine kinases (see with a collaborating SMAD molecule, of which SMAD4 Davis, 1995; Whitmarsh and Davis, 1996, for reviews) is the only one known to date. The receptor-phosphoryThe general paradigm in these pathways is that the lated SMADs carry SMAD4 into the nucleus, where they ligand-binding molecule itself possesses tyrosine kialter transcription by forming complexes with other DNAnase activity, or associates with a non-receptor tyrosine binding proteins. Antagonistic SMADs also exist, and kinase in a regulated manner, as occurs for cytokine retheir association with receptor-phosphorylated SMADs ceptors. Receptor homodimerization or cytokine recepprevents association with SMAD4 and productive nutor subunit association leads to activation of a tyrosine clear regulation. SMAD-dependent pathways can also kinase activity. The phosphorylated tyrosine substrates, be inhibited by other signaling cascades, such as MAP often including autophosphorylation of the endofacial kinase pathways. Regulation in this combinatorial sigdomains of the receptors themselves, serve as recogninaling pathway can occur at the level of receptor bindtion motifs for the binding of so-called SH2 domains in ing, hetero-oligomerization among the TGF␤ I, II, or III other molecules, thus promoting the assembly of signal isoforms, in the phosphorylation of SMADs and their transduction complexes that link surface receptor activation to changes in nuclear transcription. Receptors association with antagonistic SMADs or the SMAD4 comediator of transcriptional regulation, or in modulaand inducing a conformational change that permits or tion of these events by intervening regulatory pathways modifies preexisting binding to DNA regulatory elements activated by distinct cellular receptors, and all of these and modulation of transcription as part of a multiprotein regulatory networks represent possible loci for modifitranscriptional regulatory complex (Perlmann and Evcation by environmental agents.
ans, 1997). Jan-Å ke Gustaffson indicated that unap-G Protein-Mediated Signaling via Cell preciated diversity in steroid signaling exists, as we are Surface Receptors still discovering the molecular identity of new estrogen Martin Rodbell, one of the first investigators to recognize receptors. For example, molecular cloning has revealed the role of GTP in signal transduction and recipient of a new estrogen receptor, ER␤, which is structurally hothe 1994 Nobel Prize (with Alfred G. Gilman), in recognimologous to its well-characterized "sibling," ER␣, but tion of his discovery of G proteins, described the diverdisplays a unique tissue distribution and antagonistic sity of regulatory paradigms now appreciated to influence response to estrogen binding. Thus, whereas 17␤-estra-G protein signaling. The R a state of G protein-coupled diol binding to ER␣ leads to transcriptional activation receptors (GPCRs) interacts with and activates the hetfrom an AP1 interaction site on DNA, binding to ER␤ erotrimeric G protein. In turn, the GTP-liganded ␣ subleads to transcriptional inhibition. The anti-estrogens unit and temporarily dissociated ␤␥ subunits, serve as tamoxifen and raloxifene, defined as estrogen antagotransducers, alone or in combination, of activating signists based on their blockade of transcription via ER␣, nals to a variety of enzymes (including adenylyl cyclase, serve as potent transcriptional activators when bound phospholipases A2, C␤, and D, MAP kinase) and ion to ER␤ (Paech et al., 1997) . Consequently, responses channels (including the receptor-operated K ϩ channel elicited by environmental estrogens will be determined and voltage-sensitive Ca 2ϩ channels). The pleiotropism by the receptor, or more likely the receptors, with which of signaling that can arise subsequent to activation of these agents can interact, as well as by the tissue distri-GPCR results from the ability of these receptors to coubution of these receptors in males and females, and the ple to multiple G proteins, the ability of G protein subcellular context of estrogen-responsive elements on the units (␣ and ␤␥ dimers) to both carry signaling informa-DNA of target cells, as well as the expression of coactition, and the diversity of effectors that can be modulated vators and corepressors. by the G protein subunits (Neer, 1995) . Recently, a family Nuclear Receptors as Targets for Pollutants of functionally, but not structurally, related regulatory As indicated by William Greenlee, endogenous nuclear proteins, dubbed RGS molecules (Dohlman and Thorner, receptors that sense and respond to oxidant stress and 1997) has been described that can accelerate the turnoff environmental toxins also serve as transcription factors. of G protein-mediated pathways. Thus, G protein-mediThese nuclear receptors are of special relevance to deated signaling can be seen as a continuum of complexes veloping policy to assess the risk of exposure to environamong ligands, receptors, G protein subunits, RGS and mental toxins, as they have demonstrated roles as modeffector molecules whose coincident interactions reguulators of the actions of environmental estrogens and late cellular response. Facilitation or perturbation of these dioxins. complexes by environmental agents would thus alter 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD or dioxin) the sensitivity or the extent of the biological response, and structurally related environmental aromatic hydroor both.
carbons, as well as dietary indole carbinols, bind and Paul Insel emphasized that human diseases which activate a basic helix-loop-helix (bHLH) receptor protein, arise from mutations in G protein-coupled receptors or dubbed AhR. In its ligand-bound form, AhR interacts the G proteins themselves have been informative about with a second bHLH protein, designated as ARNT for Ah important regulatory steps in GPCR pathways. An imreceptor nuclear translocation, and the resultant AhR/ portant lesson from these diseases appears to be the ARNT heterodimer activates gene transcription by bindimpact of stoichiometry on stochastic activation of reing to dioxin-responsive enhancer elements (reviewed ceptor-G protein-effector pathways. As emphasized by in Schmidt and Bradfield, 1996) . ARNT also serves as Lee Limbird, this stoichiometry of receptor:G proteins: the heterodimerization partner for HIF-1a, a nuclear reeffectors is further controlled by microlocalization of ceptor activated by hypoxia (Semenza, 1996) , thus linkreceptors, G proteins, and effectors to discrete surface ing oxidant stress and dioxin signaling pathways through domains of target cells (Keefer et al., 1994; Neubig, 1994;  a common protein partner required for transcriptional Wozniak and Limbird, 1996) . Modeling of the activation activation of relevant target genes. of GPCRs and the resultant signaling pathways, which
The human androgen receptor, as indicated by Leorelies on estimates of receptor and effector concentranard Pinsky, plays a key regulatory role, not only in normal tions, is thus confounded by not knowing the density sexual development, but also in the pathogenesis of prosof molecular players in these presumptive signaling mitate cancer. The observation that p,pЈ-DDE, the major crodomains when compared to their concentration estimetabolite of the estrogenic pesticide DDT, is a more mated experimentally for the entire cell or tissue. Simipotent antagonist at androgen receptors than it is an larly, assessing the impact of environmental toxins on agonist at estrogen receptors (Kelce et al., 1995) , sugparticular GPCR-mediated responses also will require gests that the reported estrogenicity of p,pЈ-DDE (Soto insights into the nature of the target tissue, including et al., 1995) may reflect perturbations in the balance of the impact of signaling complex localization on the stoimodulation of androgen and estrogen receptors, and chiometry of receptors:G proteins:effectors. identifies another issue that will need to be addressed Receptors as Transcription Factors in developing and refining public policy relevant to risk The steroids, including estrogen and androgen, mediate assessment, namely predicting quantitatively the contheir pleiotropic functions by binding their cognate steroid receptors, either in the cytoplasm or in the nucleus, sequence of functionally antagonistic, additive, or even synergistic effects of individual environmental toxins on tissue samples in various background populations (for human beings or wildlife. a study carried out in St. Louis, Missouri, see Graham Jack Gorski noted that the developmental toxicity obet al., 1986) showed that the levels of TCDD, the most served in the offspring of diethylstilbestrol (DES)-treated potent and widely studied dioxin isomer, in human bemothers in the absence of discernable toxicity to the ings ranges from 5 to 10 ng/kg. To determine the amount mothers themselves has led to the hypothesis that estroof daily exposure that could lead to an accumulation gen-dependent actions on growth and development are producing an undesired outcome (e.g., liver tumors) in more sensitive than the estrogen-dependent regulation human beings over time, the relationship between expoof gene expression and physiological function in differsure, accumulation and response is evaluated in at least entiated cells. For example, estrogen-dependent regtwo rodent species in chronic feeding studies. ulation of cell growth and prolactin production in PR1
As noted by Alan Poland, the EPA has established cells, a rat estrogen-responsive cell derived by estradiolan ADI value for dioxin of 6 fg/kg/day using a linear induced pituitary tumors, appears to occur with an EC 50 multistage (LMS) extrapolation of liver tumor data from of 10 fM, which is three orders of magnitude lower that a two-year rat study (Kociba et al., 1978) . The LMS exthe EC50 for prolactin production and estradiol binding, trapolation to define cancer risk assumes that response suggesting that a minute number of estrogen receptors to a potential carcinogen is linear over the entire exponeed to be activated to elicit the growth response. Besure range; the ADI is based on an acceptable risk level fore exploiting PR1 cells as an indicator of developof 1 ϫ 10 Ϫ6 . Additional assumptions in these extrapolamental toxicity, however, it will be essential to determine tions are that the risk for tumors given a particular exporigorously whether or not these highly sensitive growth sure and fat depot accumulation is the same for human responses are mediated by the same receptor that actibeings as for the rodents, when the dose is defined as vates prolactin production, but with a different degree amount of exposure/body surface area. In light of the of amplification of the estradiol binding signal. At a minisame animal data and extant human fat depot levels, the mum, the profound sensitivity of the response to estraCanadian Ministry of Environment (Environment Candiol in this model system argues for exercising caution ada) has established an ADI for dioxin of 10 pg/kg/day, in the use of estrogen-dependent gene expression assays i.e., a value 1670 times higher than the ADI established in the development of quantitative models for predicting by the EPA. Environment Canada's risk assessment apthe potential adverse outcomes of environmental esproach uses different algorithms for extrapolating anitrogens.
mal findings to the human population, including the asEpidemiology and Public Policy sertion that there exists a no-observable-untoward side Currently, public policy concerning risk potential derives effect level (NOEL) of 0.001 g/kg/day, based on the findfrom the assessment of both animal bioassays and epiings in rodents, and a calculated safety factor of 100 to demiological data, followed by extrapolation of those account for potential interspecies differences. findings into recommendations for the general public Translating Receptor-Mediated Signaling Insights and wildlife. However, sometimes the epidemiological into Toxic Equivalency Recommendations data are limited, and thus the extrapolations are exagHow is it that limited tissue dosimetry data of potentially gerated and the public policy recommendations prematoxic substances in human adipose tissue might be ture. For example, as discussed by Ruth Allen (National linked to experimental findings in rodents by mathematiCancer Institute), carcinogenicity of organochlorine comcal assumptions that give rise to widely discrepant pubpounds such as the pesticide DDT (banned in 1972) lic policy for two countries, the USA and Canada, whose and polychlorinated biphenyl (PCB) mixtures (produced inhabitants share comparable nutrition, manufacturing between 1929 and 1977) was suggested by the observed (i.e., pollutant potential), and overall quality of life? Given correlation of an increase in the risk of breast cancer all that is known about the mechanisms of action of with serum levels of DDE in a prospective study involving endogenous substances via receptor-mediated signal-58 women in New York; a nonsignificant association of ing pathways and the probable cellular loci where envibreast cancer risk was noted with PCBs in the same ronmental toxins like dioxin or endocrine disruptors act, study (Wolff et al., 1993) . However, larger prospective wouldn't it seem reasonable to propose that, in develstudies of 150 cases of breast cancer in the San Franoping new public policy, we should take the opportunity cisco Bay area (Krieger et al., 1994) and of 240 women to incorporate these insights into our mathematical exwith breast cancer (compared with 240 control women) trapolations of acceptable exposures? Indeed, this query in the Nurses' Health Study (Hunter et al., 1997) demonwas the underlying premise for the gathering of the Restrated no overall increase in breast cancer risk with ceptor Roundtable at the close of 1997, and the reason elevated serum levels of either DDE or of PCBs. This for its joint funding by both the chemical industry and raises the dilemma of how to protect the public and the academia. natural world around us while minimizing the financial At the outset of this meeting summary, a simple model and emotional costs of overreactive policy.
of receptor occupancy and activation was outlined that Two very different regulatory approaches have been can describe, with some individualized modifications, used by agencies in the United States and Canada to virtually all of the cellular signaling pathways defined in establish acceptable daily intake (ADI) values for dioxin, molecular detail to date. Receptor occupancy is rarely an unwanted contaminant in certain commercial prodlinearly related to response, as there typically is an amucts and in the incineration of wastes containing dioxin plification of signals (cf. Figure 3 ): ‫01ف‬ 5 ions moving per precursors. The public perception of the human health conformational change of a ligand-gated ion channel; risks to dioxin has been based in part on the extreme multiple catalytic cycles of tyrosine or Ser/Thr kinase toxic potency of this compound in certain animal species and tumorigenicity in rodents. Analyses of adipose activity in activated growth and differentiation factor reveals a sigmoidal relationship between occupancy and response such that, in the absence of negative or positive cooperativity, 10% to 90% response occurs over approximately a 100-fold range of agonist concentration, "centered" about the EC 50 for agonist, the concentration of agonist that elicits a half-maximal response. (C) Typically, signal amplification occurs between receptor occupancy, effector activation, and ultimate response, such that dose-response curves (described at their midpoint by an EC 50 value) often fall to the left of receptor occupancy profiles (defined by the KD of the receptor for ligand). pectation that is not intuitive, but nonetheless argues against linear extrapolations, whether they be underreceptor-mediated cellular events where the initial ligand-receptor interactions are described by mass actaken to predict physiological responses or to assess risk to human beings secondary to environmental toxin tion law (Black et al., 1985) . In a model termed "operational agonism," Black and Leff (1983) developed a exposure. Second, the efficiency by which receptor occupancy is transduced to a biological effect can be quantitative description of the nonlinear relationship between occupancy and response. If an agonist, A, binds quantified by a descriptor, dubbed (tau), which is defined as [R0]/KE: to receptors in a bimolecular reaction driven by the relative concentrations of A and R and the AR complex (i.e., obeying mass action law), then:
It can be seen that reflects the properties of the target tissue, regardless of whether the tissue response is to Where [R 0 ] is total receptor concentration and K Da is the an endogenous agent, a drug, or an environmental toxin. equilibrium dissociation constant, M, for the agonist A.
The coefficient, n, reflects the complexity of the system; This relationship takes the form of a rectangular hywhen the system operates as a series of simple bimolecperbola, y ϭ mx/(a ϩ b), the familiar shape of ligandular reactions without cooperativity, for example, the receptor occupancy data when the amount of receptor value of n ϭ 1. However, the operational agonism model binding achieved is plotted as a function of increases also provides descriptors for experimental E/[A] curves in ligand concentration on a linear scale ( Figure 3A) . that are steeper (positively cooperative; n Ͼ 1) than When positively cooperative phenomena occur upon predicted for a simple rectangular hyperbola, such as receptor occupancy, as is characteristic of the nicotinic those linking receptor occupancy to ion translocation cholinergic receptor system described by Palmer Taylor, through the nicotinic acetylcholine receptor. Negatively then the exponent describing the [AR] complex is not cooperative phenomena are infrequently seen in biologi-1.0, but is greater than 1.0, and is determined by the cal systems, but would be described in this equation free energies describing the conformational changes by n Ͻ 1. The value is influenced not only by the that link the cooperative binding phenomena, not by the concentration of R in the tissue, including varying R number of binding sites for ligand. When cooperativity densities within a tissue due to localization of signaling occurs, this complexity is then propagated onto the complexes into discrete microenvironments if this ocsubsequent receptor-mediated signaling events.
curs, but also by the consequences of ligand-receptor To describe the link between occupancy and reinteraction, i.e., the potency of an agonist in eliciting a sponse mathematically, Black and Leff posited that the response due both to receptor affinity for the agonist concentration of the agonist-receptor complex, [AR] , and receptor efficiency in translating agonist occupancy is related to the biological effect measured, E, by a to response. rectangular hyperbolic function of [AR] :
This theoretical framework suggested to those participating in the Receptor Roundtable that it might be useful E ϭ E m[AR] K E ϩ [AR] to obtain, as a test of the validity of using operational agonism for quantitating the risk potential of particular environmental or other pollutants, the values for the Here, E m is the maximal response, E is the effect elicited at a given receptor occupancy, and K E is the concentraeffects of environmental toxins, such as endocrine disruptors, on different physiological responses. The tion of [AR] that elicits a half maximal effect. E can be 2, 3, 7, in rats. Toxicol. Appl.
value for responses in the presence of a particular toxin Pharmacol. 46, would be compared for multiple target tissues evaluated Krieger, N., Wolff, M.S., Hiatt, R.A., Rivera, M., Vogelman, J., and in more than one animal model system that serves as Orentreich, N. (1994) . Breast cancer and serum organochlorines: a a predictor for responses in human beings. If these prospective study among white, black, and Asian women. J. Natl.
values are reasonably constant for a particular environCancer Inst. 86, 589-599. mental toxin in all of these experimental settings, then Massagué , J. (1996) . TGF␤ signaling: receptors, transducers, and it would seem reasonable to propose that extrapolation The Receptor Roundtable provided a timely opportunity Ross, E.M. (1996) . Pharmacodynamics: mechanisms of drug action for evaluating how risk might better be assessed for enviand the relationship between drug concentration and effect. In The ronmental toxins, particularly those for which the molecPharmacological Basis of Therapeutics, Goodman and Gilman, eds. ular basis for their adverse effects is known. The impor-
